The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence
- 1 June 1995
- journal article
- Published by Elsevier in Surgical Oncology
- Vol. 4 (3), 163-171
- https://doi.org/10.1016/s0960-7404(10)80021-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?The Annals of Thoracic Surgery, 1992
- p53, guardian of the genomeNature, 1992
- Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.Gut, 1991
- High-grade dysplasia in the columnar-lined esophagusThe American Journal of Surgery, 1991
- Barrett's Esophagus; Development of Dysplasia and AdenocarcinomaGastroenterology, 1989
- Observer variation in the diagnosis of dysplasia in Barrett's esophagusHuman Pathology, 1988
- Barrett's EsophagusNew England Journal of Medicine, 1986
- Dysplasia in Barrett's esophagusZeitschrift für Krebsforschung und Klinische Onkologie, 1985
- Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applicationsHuman Pathology, 1983
- Barrett's EsophagusArchives of Surgery, 1983